Colorectal Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. May 15, 2003; 9(5): 965-969
Published online May 15, 2003. doi: 10.3748/wjg.v9.i5.965
Table 2 Cell growth inhibition of recombinant adenovirus on HT29 cell when combined with Ad/PGK-GV16
GroupOD (-x±s)Cell growth inhibition rates (%)
Ad/GT-TRAIL + Ad/PGK-GV160.18 ± 0.03ac85.2
Ad/GT-Bax + Ad/PGK-GV160.46 ± 0.09a61.5
Ad/GT-LacZ + Ad/PGK-GV161.05 ± 0.0712.1
PBS1.20 ± 0.170.0